BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fakhri S, Nouri Z, Moradi SZ, Akkol EK, Piri S, Sobarzo-Sánchez E, Farzaei MH, Echeverría J. Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates. Molecules 2021;26:2917. [PMID: 34068970 DOI: 10.3390/molecules26102917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Rath S, Perikala V, Jena AB, Dandapat J. Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs. Biomed Pharmacother 2021;143:112095. [PMID: 34479017 DOI: 10.1016/j.biopha.2021.112095] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Satoh T, Trudler D, Oh C, Lipton SA. Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome. Antioxidants 2022;11:124. [DOI: 10.3390/antiox11010124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Mujwar S, Sun L, Fidan O. In silico evaluation of food-derived carotenoids against SARS-CoV-2 drug targets: Crocin is a promising dietary supplement candidate for COVID-19. J Food Biochem 2022;:e14219. [PMID: 35545850 DOI: 10.1111/jfbc.14219] [Reference Citation Analysis]
4 Kelleni MT. NSAIDs and Kelleni's protocol as potential early COVID-19 treatment game changer: could it be the final countdown? Inflammopharmacology 2021. [PMID: 34822026 DOI: 10.1007/s10787-021-00896-7] [Reference Citation Analysis]
5 Fakhri S, Moradi SZ, Yarmohammadi A, Narimani F, Wallace CE, Bishayee A. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy. Front Oncol 2022;12:834072. [PMID: 35299751 DOI: 10.3389/fonc.2022.834072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Fakhri S, Moradi SZ, Ash-Rafzadeh A, Bishayee A. Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review. Pharmacol Res 2021;:105961. [PMID: 34718135 DOI: 10.1016/j.phrs.2021.105961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hasan AH, Hussen NH, Shakya S, Jamalis J, Pratama MRF, Chander S, Kharkwal H, Murugesan S. In silico discovery of multi-targeting inhibitors for the COVID-19 treatment by molecular docking, molecular dynamics simulation studies, and ADMET predictions. Struct Chem. [DOI: 10.1007/s11224-022-01996-y] [Reference Citation Analysis]
8 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]